Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $6.24 Million - $12.4 Million
388,603 Added 27.24%
1,815,053 $52.4 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $24.4 Million - $38.4 Million
1,426,450 New
1,426,450 $29.4 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $68.5 Million - $106 Million
-2,653,406 Reduced 97.76%
60,879 $1.8 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $56.8 Million - $103 Million
2,714,285 New
2,714,285 $97.2 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $7.81 Million - $10.9 Million
178,942 New
178,942 $9.63 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $3.96 Million - $8.25 Million
-82,100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $7.28 Million - $9.89 Million
82,100 New
82,100 $8.21 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $9.24 Million - $12.4 Million
-93,596 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $10.3 Million - $15.5 Million
93,596 New
93,596 $11.6 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $4.62 Million - $6.51 Million
-36,360 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $15.5 Million - $21 Million
-154,856 Reduced 80.98%
36,360 $4.69 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $15.4 Million - $21.4 Million
191,216 New
191,216 $21.4 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $5.59 Million - $8.41 Million
-94,646 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $39.9 Million - $55.5 Million
-670,377 Reduced 87.63%
94,646 $7.4 Million
Q3 2019

Nov 15, 2019

BUY
$62.59 - $110.3 $47.5 Million - $83.8 Million
759,442 Added 13607.63%
765,023 $48.8 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $58,121 - $82,818
909 Added 19.46%
5,581 $482,000
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $160,249 - $457,762
4,672 New
4,672 $358,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.